Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10285953 Sublingual films

Patent 10285953 was granted and assigned to Sunovion Pharmaceuticals Inc. on May, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Michael Clinton Koons0

Nathan John Bryson0

Scott David Barnhart0

Anthony John Giovinazzo0

Date of Patent

May 14, 2019

0

Patent Application Number

152259920

Date Filed

August 2, 2016

0

Patent Citations Received

US Patent 12109196 Non-sedating dexmedetomidine treatment regimens

0

US Patent 11497711 Film formulations containing dexmedetomidine and methods of producing them

US Patent 11839604 Use of sublingual dexmedetomidine for the treatment of agitation

0

US Patent 11890272 Non-sedating dexmedetomidine treatment regimens

0

US Patent 11931340 Use of sublingual dexmedetomidine for the treatment of agitation

0

US Patent 11998528 Non-sedating dexmedetomidine treatment regimens

0

US Patent 11998529 Non-sedating dexmedetomidine treatment regimens

0

US Patent 12090140 Non-sedating dexmedetomidine treatment regimens

0

...

Patent Primary Examiner

0

Patent abstract

The invention features sublingual film formulations of dopamine agonists and methods of treating Parkinson's disease, tremors, restless leg syndrome, sexual dysfunction, and depressive disorders therewith.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10285953 Sublingual films

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool